These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3418629)
1. Phenylbutazone compared to piroxicam in symptomatic relief of degenerative joint disease. Klinefelter HF J Rheumatol; 1988 Jun; 15(6):1034-5. PubMed ID: 3418629 [No Abstract] [Full Text] [Related]
2. Meclofenamate sodium, phenylbutazone, and naproxen in the treatment of degenerative joint disease. Report of a placebo-controlled double-blind clinical comparison. López Sánchez J; Yañez Marchena G Arzneimittelforschung; 1983; 33(4A):653-6. PubMed ID: 6349651 [TBL] [Abstract][Full Text] [Related]
3. [Diphenylbutazone--isopyrine combination in the treatment of degenerative rheumatism]. Anciaux H Brux Med; 1967 Apr; 47(15):387-94. PubMed ID: 5619367 [No Abstract] [Full Text] [Related]
4. [Results of Myobutazolidin medication for patients with temporomandibular joint diseases]. Omori K; Sasaki J; Suzuki M; Otsuki K; Segawa M Shikwa Gakuho; 1966 Apr; 66(4):567-72. PubMed ID: 5220508 [No Abstract] [Full Text] [Related]
5. Use of phenylbutazone in locomotor and vascular diseases. Udvardi G Ther Hung; 1984; 32(3):130-3. PubMed ID: 6571197 [No Abstract] [Full Text] [Related]
6. [Comparison of a vitamin-containing and a vitamin-free phenylbutazone preparation in chronic degenerative spinal and joint diseases]. Bischoff HP Wien Med Wochenschr; 1974 Nov; 124(48):710-1. PubMed ID: 4432522 [No Abstract] [Full Text] [Related]
7. [Midalgyl in rheumatology. Study on 50 patients]. Laborie G Bord Med; 1971 Sep; 4(9):2471-2 passim. PubMed ID: 5315933 [No Abstract] [Full Text] [Related]
8. [Clinical evaluation in 42 rheumatic patients of a new pyrazole derivative: pyrazinobutazone or Carudol]. Delhaye JP; Famaey JP J Dent Assoc S Afr; 1973; 28(1):14-22. PubMed ID: 4542571 [No Abstract] [Full Text] [Related]
9. [The anti-inflammatory clinical effects of pyrazinobutazone (study of 44 cases with principally rheumatologic indications)]. Le Chevallier PL Rhumatologie; 1972 Mar; 24(3):91-100. PubMed ID: 4538813 [No Abstract] [Full Text] [Related]
10. [Clinical trial of a new anti-inflammatory agent in rheumatology, ANP 3260 or clofezone]. Verhaeghe A; Lesage R; Delcambre B Lille Med; 1968 Mar; 13(3):Suppl:260-5. PubMed ID: 4927184 [No Abstract] [Full Text] [Related]
11. [Value of pyrazinobutazone in the treatment of different inflammatory states]. Gaillarde B; Ortonne JP; Pugeat M; Plauchu M J Med Lyon; 1972 Oct; 53(234):1315-6 passim. PubMed ID: 4539046 [No Abstract] [Full Text] [Related]
12. [Recent acquisitions in anti-inflammatory therapy in rheumatology]. Saporta L; Massias P Therapeutique; 1970 Nov; 46(9):937-9. PubMed ID: 5486145 [No Abstract] [Full Text] [Related]
13. [Arthrosis of the knee. Clinical and therapeutic studies]. Carneiro RA; Bittencourt W Hospital (Rio J); 1969 Jan; 75(1):Suppl:3-18. PubMed ID: 5304700 [No Abstract] [Full Text] [Related]
14. Combined phenylbutazone and prednisone in acute rheumatic disorders. Settel E Curr Ther Res Clin Exp; 1966 Jun; 8(6):287-90. PubMed ID: 4956513 [No Abstract] [Full Text] [Related]
16. [Treatment of degenerative rheumatic diseases. Therapy of painful irritation-conditions of the spine and of periarthrosis using a new combination preparation]. Gerhold H Fortschr Med; 1974 Aug; 92(22):958-61. PubMed ID: 4547109 [No Abstract] [Full Text] [Related]
17. [Jaundice caused by phenylbutazone. Presentation of 4 cases]. Findor J; Fried L; Garibotto R; Stapler N Prensa Med Argent; 1965 Dec; 52(49):3048-52. PubMed ID: 5888462 [No Abstract] [Full Text] [Related]
18. [Meprotixol (N 7020). Clinical experiences in rheumatic diseases]. Kogstad O Tidsskr Nor Laegeforen; 1974 Feb; 94(4):212-4. PubMed ID: 4595469 [No Abstract] [Full Text] [Related]
19. [The combination of ultrasound and phenylbutazone--its therapeutic action (preliminary observations)]. Wettreich W Hospital (Rio J); 1965 Aug; 68(2):427-34. PubMed ID: 5295131 [No Abstract] [Full Text] [Related]